AUTHOR=Jing Jia , Rui Li , Junyuan Sun , Jinfeng Yang , Zhihao Hong , Weiguo Lu , Zhenyu Jia 

TITLE=Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review

JOURNAL=Frontiers in Pharmacology

VOLUME=14

YEAR=2023

URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1122008

DOI=10.3389/fphar.2023.1122008

ISSN=1663-9812

ABSTRACT=<p>S-phase kinase-associated protein 2 (Skp2) is a substrate-specific adaptor in Skp1-CUL1-ROC1-F-box E3 ubiquitin ligases and widely regarded as an oncogene. Therefore, Skp2 has remained as an active anticancer research topic since its discovery. Accordingly, the structure of Skp2 has been solved and numerous Skp2 inhibiting compounds have been identified. In this review, we would describe the structural features of Skp2, introduce the ubiquitination function of SCF<sup>Skp2</sup>, and summarize the diverse natural and synthetic Skp2 inhibiting compounds reported to date. The IC<sub>50</sub> data of the Skp2 inhibitors or inhibiting compounds in various kinds of tumors at cellular levels implied that the cancer type, stage and pathological mechanisms should be taken into consideration when selecting Skp2-inhibiting compound for cancer treatment.</p>